NR
Nageswara Rao Pulipati
About Nageswara Rao Pulipati
Data last updated:
Nageswara Rao Pulipati is a Director at Bycus Therapeutics Private Limited (since 2020) and Designated Partner at Bycus Bio Sciences Llp (since 2022). The companies operate in Life Sciences. The largest current company by reported revenue is Bycus Therapeutics Private Limited at ₹3.98 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bycus Therapeutics Private Limited U73200TG2020PTC140175 | Director | 23 Apr 2020 | 2020 | ₹3.98 Cr (FY 2025) | Active |
| Bycus Bio Sciences Llp ABA-5934 | Designated Partner | 10 Feb 2022 | 2022 | Active |
Board colleagues of Nageswara Rao Pulipati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lavanya Sunkara | 06434012 | Bycus Therapeutics Private Limited , Bycus Bio Sciences Llp | Director |
| Nishanth Pasaru | 06770858 | Bycus Therapeutics Private Limited , Bycus Bio Sciences Llp | Director |
| Akila Chandrashekar Raju | 07590312 | Bycus Bio Sciences Llp | Designated Partner |
| Venkata Cherish Babu Pelluri | 08373892 | Bycus Bio Sciences Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nageswara Rao Pulipati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nageswara Rao Pulipati
Nageswara Rao Pulipati currently holds 2 directorships: Bycus Therapeutics Private Limited (Director, since 23 Apr 2020, revenue ₹3.98 Cr (FY 2025)); Bycus Bio Sciences Llp (Designated Partner, since 10 Feb 2022).
Nageswara Rao Pulipati was first appointed on 23 Apr 2020 as Director at Bycus Therapeutics Private Limited. The most recent appointment on record is 10 Feb 2022 at Bycus Bio Sciences Llp.
The current boards of Nageswara Rao Pulipati's companies include Lavanya Sunkara (Bycus Therapeutics Private Limited), Nishanth Pasaru (Bycus Therapeutics Private Limited), Akila Chandrashekar Raju (Bycus Bio Sciences Llp), Venkata Cherish Babu Pelluri (Bycus Bio Sciences Llp).